Form 4: LENSAR Director Todd Hammer Reports Acquisition of Restricted Stock Units as Annual Compensation

LENSAR, Inc. Director and 10% owner Todd Hammer reported the acquisition of 7,374 restricted stock units as part of his annual compensation, vesting in May 2026.

Summary

• Todd B. Hammer, a Director and 10% owner of LENSAR, Inc. (LNSR), acquired 7,374 shares of common stock on May 23, 2025.
• These shares were granted as Restricted Stock Units (RSUs) at an acquisition price of $0.
• The RSUs are scheduled to vest in full on May 23, 2026, contingent upon Mr. Hammer's continued service to the company through that date.
• Settlement of the RSUs will occur upon the earliest of Mr. Hammer's termination of service, a change in control of the Company, or his death or disability.
• This grant is consistent with the Issuer's non-employee director compensation program, serving as a component of Mr. Hammer's annual compensation for his service.
• Following this transaction, Mr. Hammer directly beneficially owns 38,662 shares and indirectly beneficially owns 1,110,592 shares through North Run Capital, LP, and North Run Advisors, LLC.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing reports a routine equity grant to a director, which aligns interests but doesn't indicate significant new financial performance or strategic shifts. The grant itself is a positive for aligning interests.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their long-term interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• The transaction is part of a standard non-employee director compensation program, indicating routine corporate governance and a structured approach to executive incentives.

Risks

• The vesting of the 7,374 Restricted Stock Units is subject to Todd B. Hammer's continued service to LENSAR, Inc. through May 23, 2026; failure to meet this condition could result in forfeiture of the unvested units.
• The ultimate value of the acquired RSUs upon vesting is dependent on the future market price of LENSAR, Inc. common stock, introducing market price volatility risk.

Future Outlook

The future outlook for the reporting person's compensation includes the vesting of 7,374 Restricted Stock Units on May 23, 2026, contingent on continued service, which will convert into common stock.

Management Comments

• The Restricted Stock Units were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.

Industry Context

This Form 4 filing details a routine equity compensation grant to a non-employee director, a common practice across various industries, including medical technology, to align director incentives with long-term company performance and shareholder interests.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) as part of non-employee director compensation is a common practice across various industries, including medical technology and ophthalmology, as it aligns the director's interests with long-term shareholder value.
• The $0 acquisition price for RSUs is standard for equity grants as compensation, differentiating them from stock options which typically have an exercise price.
• A one-year vesting period (May 2025 to May 2026) for annual director RSU grants is within typical industry norms, though longer vesting periods or performance-based vesting can also be observed depending on company-specific compensation philosophies.

Corporate Governance

Related Party Transactions

• The indirect beneficial ownership of 1,110,592 shares through North Run Capital, LP, and North Run Advisors, LLC, where the reporting person is a member, constitutes a related party arrangement for beneficial ownership reporting purposes.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with long-term shareholder value, as the value of the compensation is directly tied to the company's stock performance.

Next Steps

• Vesting of the 7,374 Restricted Stock Units on May 23, 2026, subject to the reporting person's continued service.
• Settlement of the RSUs upon vesting or earlier triggering events such as termination of service, a change in control of the company, or the reporting person's death or disability.

Key Dates

Recommendation

Keywords

LENSAR, LNSR, SEC Form 4, insider transaction, restricted stock units, RSU, director compensation, beneficial ownership, equity grant